Shingo Togano

542 total citations
27 papers, 256 citations indexed

About

Shingo Togano is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shingo Togano has authored 27 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Shingo Togano's work include Gastric Cancer Management and Outcomes (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Metastasis and carcinoma case studies (4 papers). Shingo Togano is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Metastasis and carcinoma case studies (4 papers). Shingo Togano collaborates with scholars based in Japan. Shingo Togano's co-authors include Masaichi Ohira, Masakazu Yashiro, Tomohisa Okuno, Kenji Kuroda, Yurie Yamamoto, Atsushi Sugimoto, Yuichiro Miki, Go Masuda, Kenji Kuroda and Kosei Hirakawa and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Shingo Togano

24 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingo Togano Japan 10 124 107 72 60 50 27 256
Jimin Min United States 9 97 0.8× 74 0.7× 51 0.7× 52 0.9× 35 0.7× 15 228
D. Roda Spain 4 115 0.9× 116 1.1× 98 1.4× 112 1.9× 102 2.0× 9 296
Minae An South Korea 6 110 0.9× 189 1.8× 49 0.7× 95 1.6× 79 1.6× 10 309
Natasha Di Costanzo Australia 6 136 1.1× 156 1.5× 54 0.8× 76 1.3× 140 2.8× 6 337
Jiamin Chen United States 3 150 1.2× 132 1.2× 94 1.3× 57 0.9× 115 2.3× 3 278
Yiyi Xi China 8 186 1.5× 136 1.3× 101 1.4× 66 1.1× 76 1.5× 9 315
Huiyun Cai China 8 127 1.0× 110 1.0× 81 1.1× 31 0.5× 56 1.1× 16 279
Grégoire F. Le Bras United States 9 203 1.6× 127 1.2× 69 1.0× 47 0.8× 24 0.5× 11 324
Mara Persano Italy 6 126 1.0× 159 1.5× 84 1.2× 57 0.9× 46 0.9× 31 274
Cigdem Ussakli United States 8 111 0.9× 155 1.4× 73 1.0× 72 1.2× 26 0.5× 10 308

Countries citing papers authored by Shingo Togano

Since Specialization
Citations

This map shows the geographic impact of Shingo Togano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Togano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Togano more than expected).

Fields of papers citing papers by Shingo Togano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Togano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Togano. The network helps show where Shingo Togano may publish in the future.

Co-authorship network of co-authors of Shingo Togano

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Togano. A scholar is included among the top collaborators of Shingo Togano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Togano. Shingo Togano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akita, Kaoru, Shingo Togano, Masakazu Yashiro, et al.. (2023). Trophoblast cell surface antigen-2 phosphorylation triggered by binding of galectin-3 drives metastasis through down-regulation of E-cadherin. Journal of Biological Chemistry. 299(8). 104971–104971. 5 indexed citations
2.
Sakuma, Takashi, Yurie Yamamoto, Atsushi Sugimoto, et al.. (2022). Candidate Oncogenes,ARHGAP4, NOS3, andOR51B5, for the Development of Scirrhous-type Gastric Cancer. Anticancer Research. 42(11). 5195–5203. 5 indexed citations
3.
Yamamoto, Yurie, Atsushi Sugimoto, Kenji Kuroda, et al.. (2022). CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. PLoS ONE. 17(4). e0266027–e0266027. 9 indexed citations
4.
Yamamoto, Yurie, Atsushi Sugimoto, Shingo Togano, et al.. (2022). Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer. Gastric Cancer. 25(5). 850–861. 14 indexed citations
5.
Sugimoto, Atsushi, Tomohisa Okuno, Yurie Yamamoto, et al.. (2021). The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients. PLoS ONE. 16(7). e0253702–e0253702. 5 indexed citations
6.
Sugimoto, Atsushi, Shingo Togano, Kenji Kuroda, et al.. (2021). Clinical benefit for clinical sequencing using cancer panel testing. PLoS ONE. 16(2). e0247090–e0247090. 3 indexed citations
7.
Yashiro, Masakazu, Yurie Yamamoto, Atsushi Sugimoto, et al.. (2021). Dipeptidyl Peptidase-4 from Cancer-associated Fibroblasts Stimulates the Proliferation of Scirrhous-type Gastric Cancer Cells. Anticancer Research. 42(1). 501–509. 7 indexed citations
8.
Sugimoto, Atsushi, Tomohisa Okuno, Yuichiro Miki, et al.. (2021). EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells. Cancer Letters. 521. 169–177. 6 indexed citations
9.
Yashiro, Masakazu, Kenji Kuroda, Go Masuda, et al.. (2021). Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer. Scientific Reports. 11(1). 4698–4698. 17 indexed citations
10.
Togano, Shingo, Masakazu Yashiro, Go Masuda, et al.. (2021). Gastric cancer stem cells survive in stress environments via their autophagy system. Scientific Reports. 11(1). 20664–20664. 19 indexed citations
11.
Yashiro, Masakazu, Yurie Yamamoto, Atsushi Sugimoto, et al.. (2021). Clinicopathologic significance of TROP2 and phospho‑TROP2 in gastric cancer. Molecular and Clinical Oncology. 14(5). 105–105. 8 indexed citations
12.
Togano, Shingo, Masakazu Yashiro, Yuichiro Miki, et al.. (2020). Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer. PLoS ONE. 15(1). e0225958–e0225958. 7 indexed citations
13.
Miki, Yuichiro, Masakazu Yashiro, Kenji Kuroda, et al.. (2020). Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer. Cancer Medicine. 10(2). 521–528. 17 indexed citations
14.
Kuroda, Kenji, Masakazu Yashiro, Yuichiro Miki, et al.. (2020). Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor. Cancer Science. 111(12). 4500–4509. 17 indexed citations
15.
Yashiro, Masakazu, Yurie Yamamoto, Atsushi Sugimoto, et al.. (2019). Feasibility of Identifying Patients at High Risk of Hereditary Gastric Cancer Based on Clinicopathological Variables. Anticancer Research. 39(9). 5057–5064. 2 indexed citations
16.
Yamamoto, Yurie, Kenji Kuroda, Atsushi Sugimoto, et al.. (2019). The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer. Anticancer Research. 39(12). 6645–6652. 36 indexed citations
17.
Kuroda, Kenji, Masakazu Yashiro, Yurie Yamamoto, et al.. (2019). The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer. PLoS ONE. 14(11). e0224727–e0224727. 22 indexed citations
18.
Tsukamoto, Tadashi, Shingo Togano, Hisao Tanaka, et al.. (2019). [A Resected Case of Retroperitoneal Metastasis and Small Bowel Metastasis from HCC].. PubMed. 46(13). 2297–2299.
19.
Okuno, Tomohisa, Masakazu Yashiro, Go Masuda, et al.. (2019). Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14. Annals of Surgical Oncology. 26(4). 1093–1102. 9 indexed citations
20.
Miki, Yuichiro, Masakazu Yashiro, Tomohisa Okuno, et al.. (2018). Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer. PLoS ONE. 13(9). e0202956–e0202956. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jimin Min Breakdown of academic impact, for papers by D. Roda Breakdown of academic impact, for papers by Minae An Breakdown of academic impact, for papers by Natasha Di Costanzo Breakdown of academic impact, for papers by Jiamin Chen Breakdown of academic impact, for papers by Yiyi Xi Breakdown of academic impact, for papers by Huiyun Cai Breakdown of academic impact, for papers by Grégoire F. Le Bras Breakdown of academic impact, for papers by Mara Persano Breakdown of academic impact, for papers by Cigdem Ussakli
Rankless by CCL
2026